ID   HNRPK_BOVIN             Reviewed;         464 AA.
AC   Q3T0D0;
DT   13-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2005, sequence version 1.
DT   07-APR-2021, entry version 123.
DE   RecName: Full=Heterogeneous nuclear ribonucleoprotein K;
DE            Short=hnRNP K;
GN   Name=HNRNPK; Synonyms=HNRPK;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Crossbred X Angus; TISSUE=Ileum;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: One of the major pre-mRNA-binding proteins. Binds tenaciously
CC       to poly(C) sequences. Likely to play a role in the nuclear metabolism
CC       of hnRNAs, particularly for pre-mRNAs that contain cytidine-rich
CC       sequences. Can also bind poly(C) single-stranded DNA. Plays an
CC       important role in p53/TP53 response to DNA damage, acting at the level
CC       of both transcription activation and repression. When sumoylated, acts
CC       as a transcriptional coactivator of p53/TP53, playing a role in
CC       p21/CDKN1A and 14-3-3 sigma/SFN induction. As far as transcription
CC       repression is concerned, acts by interacting with long intergenic RNA
CC       p21 (lincRNA-p21), a non-coding RNA induced by p53/TP53. This
CC       interaction is necessary for the induction of apoptosis, but not cell
CC       cycle arrest (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Identified in the spliceosome C complex. Interacts with
CC       ANKRD28, RBM42 and ZIK1. Interacts with DDX1. Interacts with MDM2; this
CC       interaction leads to ubiquitination and proteasomal degradation.
CC       Interacts with p53/TP53. Interacts with BRDT (By similarity). Interacts
CC       with IVNS1ABP (By similarity).Interacts with PPIA/CYPA (By similarity).
CC       {ECO:0000250|UniProtKB:P61978, ECO:0000250|UniProtKB:P61979,
CC       ECO:0000250|UniProtKB:P61980}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P61978}.
CC       Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P61978}. Cell projection,
CC       podosome {ECO:0000250|UniProtKB:P61978}.
CC   -!- PTM: Sumoylated by CBX4. Sumoylation is increased upon DNA damage, such
CC       as that produced by doxorubicin, etoposide, UV light and camptothecin,
CC       due to enhanced CBX4 phosphorylation by HIPK2 under these conditions
CC       (By similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated by MDM2. Doxorubicin treatment does not affect
CC       monoubiquitination, but slightly decreases HNRNPK poly-ubiquitination
CC       (By similarity). {ECO:0000250}.
CC   -!- PTM: O-glycosylated (O-GlcNAcylated), in a cell cycle-dependent manner.
CC       {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC102450; AAI02451.1; -; mRNA.
DR   RefSeq; NP_001029734.1; NM_001034562.1.
DR   RefSeq; XP_005210386.1; XM_005210329.3.
DR   RefSeq; XP_005210387.1; XM_005210330.2.
DR   RefSeq; XP_005210388.1; XM_005210331.3.
DR   SMR; Q3T0D0; -.
DR   STRING; 9913.ENSBTAP00000028162; -.
DR   iPTMnet; Q3T0D0; -.
DR   PaxDb; Q3T0D0; -.
DR   PeptideAtlas; Q3T0D0; -.
DR   PRIDE; Q3T0D0; -.
DR   Ensembl; ENSBTAT00000028162; ENSBTAP00000028162; ENSBTAG00000021131.
DR   GeneID; 528135; -.
DR   KEGG; bta:528135; -.
DR   CTD; 3190; -.
DR   VGNC; VGNC:29897; HNRNPK.
DR   eggNOG; KOG2192; Eukaryota.
DR   GeneTree; ENSGT00940000153434; -.
DR   HOGENOM; CLU_022670_5_1_1; -.
DR   InParanoid; Q3T0D0; -.
DR   OMA; DCTGPER; -.
DR   OrthoDB; 394765at2759; -.
DR   TreeFam; TF316335; -.
DR   Proteomes; UP000009136; Chromosome 8.
DR   Bgee; ENSBTAG00000021131; Expressed in spermatocyte and 18 other tissues.
DR   ExpressionAtlas; Q3T0D0; baseline.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; IEA:Ensembl.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0042995; C:cell projection; IEA:UniProtKB-KW.
DR   GO; GO:0000785; C:chromatin; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0010494; C:cytoplasmic stress granule; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0002102; C:podosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0003729; F:mRNA binding; IBA:GO_Central.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; IEA:Ensembl.
DR   GO; GO:1905599; P:positive regulation of low-density lipoprotein receptor activity; IEA:Ensembl.
DR   GO; GO:0048260; P:positive regulation of receptor-mediated endocytosis; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0010468; P:regulation of gene expression; IBA:GO_Central.
DR   GO; GO:1902165; P:regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl.
DR   GO; GO:0010988; P:regulation of low-density lipoprotein particle clearance; IEA:Ensembl.
DR   GO; GO:0048024; P:regulation of mRNA splicing, via spliceosome; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.1370.10; -; 3.
DR   InterPro; IPR033090; hnRNP_K.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   InterPro; IPR012987; ROK_N.
DR   PANTHER; PTHR10288:SF262; PTHR10288:SF262; 1.
DR   Pfam; PF00013; KH_1; 3.
DR   Pfam; PF08067; ROKNT; 1.
DR   SMART; SM00322; KH; 3.
DR   SUPFAM; SSF54791; SSF54791; 3.
DR   PROSITE; PS50084; KH_TYPE_1; 3.
PE   2: Evidence at transcript level;
KW   Acetylation; Activator; Cell junction; Cell projection; Cytoplasm;
KW   DNA-binding; Glycoprotein; Isopeptide bond; Methylation; mRNA processing;
KW   mRNA splicing; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Repressor; Ribonucleoprotein; RNA-binding; Spliceosome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..464
FT                   /note="Heterogeneous nuclear ribonucleoprotein K"
FT                   /id="PRO_0000239836"
FT   DOMAIN          42..104
FT                   /note="KH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   REPEAT          54..76
FT                   /note="1-1"
FT   REPEAT          59..62
FT                   /note="3-1"
FT   DOMAIN          144..209
FT                   /note="KH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   REPEAT          245..250
FT                   /note="2-1"
FT   REPEAT          257..260
FT                   /note="3-2"
FT   REPEAT          267..270
FT                   /note="3-3"
FT   REPEAT          295..298
FT                   /note="3-4"
FT   REPEAT          324..329
FT                   /note="2-2"
FT   DOMAIN          387..451
FT                   /note="KH 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   REPEAT          399..421
FT                   /note="1-2"
FT   REPEAT          404..407
FT                   /note="3-5"
FT   REGION          1..276
FT                   /note="Necessary for interaction with DDX1"
FT                   /evidence="ECO:0000250"
FT   REGION          54..421
FT                   /note="2 X 22 AA approximate repeats"
FT   REGION          59..407
FT                   /note="5 X 4 AA repeats of G-X-G-G"
FT   REGION          209..337
FT                   /note="Interaction with ZIK1"
FT                   /evidence="ECO:0000250"
FT   REGION          236..273
FT                   /note="RNA-binding RGG-box"
FT   REGION          245..329
FT                   /note="2 X 6 AA approximate repeats"
FT   COMPBIAS        289..294
FT                   /note="Poly-Pro"
FT   COMPBIAS        310..315
FT                   /note="Poly-Pro"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         34
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61979"
FT   MOD_RES         36
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         39
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P61979"
FT   MOD_RES         75
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         116
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         198
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P61979"
FT   MOD_RES         214
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         216
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         219
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61979"
FT   MOD_RES         284
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         316
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         377
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P61979"
FT   MOD_RES         379
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         380
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         405
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61979"
FT   MOD_RES         420
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        34
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        34
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        52
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        60
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        163
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        163
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        219
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        405
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        422
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        422
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        422
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
SQ   SEQUENCE   464 AA;  51019 MW;  264011C2D457BF92 CRC64;
     METEQPEETF PNTETNGEFG KRPAEDMEEE QAFKRSRNTD EMVELRILLQ SKNAGAVIGK
     GGKNIKALRT DYNASVSVPD SSGPERILSI SADIETIGEI LKKIIPTLEE GLQLPSPTAT
     SQLPLESDAV ECLNYQHYKG SDFDCELRLL IHQSLAGGII GVKGAKIKEL RENTQTTIKL
     FQECCPQSTD RVVLIGGKPD RVVECIKIIL DLISESPIKG RAQPYDPNFY DETYDYGGFT
     MMFDDRRGRP VGFPMRGRGG FDRMPPGRGG RPMPPSRRDY DDMSPRRGPP PPPPGRGGRG
     GSRARNLPLP PPPPPRGGDL MAYDRRGRPG DRYDGMVGFS ADETWDSAID TWSPSEWQMA
     YEPQGGSGYD YSYAGGRGSY GDLGGPIITT QVTIPKDLAG SIIGKGGQRI KQIRHESGAS
     IKIDEPLEGS EDRIITITGT QDQIQNAQYL LQNSVKQYAD VEGF
//
